Craig R Stapleton - Net Worth and Insider Trading
Craig R Stapleton Net Worth
The estimated net worth of Craig R Stapleton is at least $16 Million dollars as of 2024-04-26. Craig R Stapleton is the Director of Avadel Pharmaceuticals PLC and owns about 503,413 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $9 Million. Craig R Stapleton is also the Director of Abercrombie & Fitch Co and owns about 57,398 shares of Abercrombie & Fitch Co (ANF) stock worth over $7 Million. Details can be seen in Craig R Stapleton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Craig R Stapleton has not made any transactions after 2017-12-15 and currently still holds the listed stock(s).
Transaction Summary of Craig R Stapleton
Craig R Stapleton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Craig R Stapleton owns 4 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , Abercrombie & Fitch Co (ANF) , and Reata Pharmaceuticals Inc (RETA) among others .
Click here to see the complete history of Craig R Stapleton’s form 4 insider trades.
Insider Ownership Summary of Craig R Stapleton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2017-12-15 | director |
| ANF | Abercrombie & Fitch Co | 2016-09-01 | director |
| RETA | Reata Pharmaceuticals Inc | 2016-06-01 | 10 percent owner |
| TMUS | T-Mobile US Inc | 2004-07-28 | director |
Craig R Stapleton Latest Holdings Summary
Craig R Stapleton currently owns a total of 2 stocks. Among these stocks, Craig R Stapleton owns 503,413 shares of Avadel Pharmaceuticals PLC (AVDL) as of December 15, 2017, with a value of $9 Million and a weighting of 57.51%. Craig R Stapleton also owns 57,398 shares of Abercrombie & Fitch Co (ANF) as of September 1, 2016, with a value of $7 Million and a weighting of 42.49%.
Latest Holdings of Craig R Stapleton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2017-12-15 | 503,413 | 17.82 | 8,970,820 |
| ANF | Abercrombie & Fitch Co | 2016-09-01 | 57,398 | 115.45 | 6,626,599 |
Holding Weightings of Craig R Stapleton
Craig R Stapleton Form 4 Trading Tracker
According to the SEC Form 4 filings, Craig R Stapleton has made a total of 0 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years. The most-recent trade in Avadel Pharmaceuticals PLC is the acquisition of 140,000 shares on December 15, 2017, which cost Craig R Stapleton around $1 Million.
According to the SEC Form 4 filings, Craig R Stapleton has made a total of 0 transactions in Abercrombie & Fitch Co (ANF) over the past 5 years. The most-recent trade in Abercrombie & Fitch Co is the acquisition of 10,000 shares on September 1, 2016, which cost Craig R Stapleton around $176,500.
Insider Trading History of Craig R Stapleton
- 1
Craig R Stapleton Trading Performance
GuruFocus tracks the stock performance after each of Craig R Stapleton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Craig R Stapleton is -2.29%. GuruFocus also compares Craig R Stapleton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Craig R Stapleton within 3 months outperforms 4 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Craig R Stapleton's insider trading performs compared to the benchmark.
Performance of Craig R Stapleton
Average Return
-14.57%
Outperforming Transactions
29%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.04 | -2.29 | -1.73 | -14.57 | -24.86 | -19.88 |
| Relative Return to S&P 500(%) | 1.01 | -6.16 | -10.58 | -27.54 | -37.63 | -30.87 |
Craig R Stapleton Ownership Network
Ownership Network List of Craig R Stapleton
Ownership Network Relation of Craig R Stapleton
Craig R Stapleton Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Craig R Stapleton is the director of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Craig R Stapleton made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 9,000 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 33,000 shares made by Eric J Ende .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 70,500 shares were bought by its insiders, resulting in a net sale of 33,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Craig R Stapleton Mailing Address
Above is the net worth, insider trading, and ownership report for Craig R Stapleton. You might contact Craig R Stapleton via mailing address: 55 Old Field Point Road, Suite 2, Greenwich Ct 06830.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
